Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
8.74
-0.09 (-1.02%)
Apr 29, 2026, 2:22 PM EDT - Market open
Kura Oncology Employees
Kura Oncology had 260 employees as of December 31, 2025. The number of employees increased by 68 or 35.42% compared to the previous year.
Employees
260
Change (1Y)
68
Growth (1Y)
35.42%
Revenue / Employee
$259,546
Profits / Employee
-$1,071,792
Market Cap
775.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 163 |
| Allogene Therapeutics | 152 |
| Absci | 140 |
| Solid Biosciences | 121 |
| Cullinan Therapeutics | 109 |
| Vor Biopharma | 76 |
| Design Therapeutics | 54 |
| Crescent Biopharma | 44 |
KURA News
- 5 days ago - Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML - GlobeNewsWire
- 12 days ago - Kura Oncology Advances Kidney Cancer Program With Solid Early-Stage Results - Benzinga
- 12 days ago - Kura Oncology Transcript: Investor Update - Transcripts
- 12 days ago - Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib - GlobeNewsWire
- 20 days ago - Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026 - GlobeNewsWire
- 26 days ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Kura Oncology Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Kura Oncology Transcript: Leerink Global Healthcare Conference 2026 - Transcripts